Immunogenicity, safety and consistency of seven lots of an inactivated COVID-19 vaccine in healthy children and adolescents: a randomized, double-blind, controlled, phase IV clinical trial

Immunogenicity, safety and consistency of seven lots of an inactivated COVID-19 vaccine in healthy children and adolescents: a randomized, double-blind, controlled, phase IV clinical trial

BackgroundCoronaVac has been authorized worldwide for preventing coronavirus disease 2019. Information on the safety, immunogenicity and consistency of different lots and workshops of CoronaVac is presented here.MethodsIn this randomized, double-blind, phase IV clinical trial in healthy children and...

Full description

Bibliographic Details
Main Authors: Weijun Hu, Xiaoyu Liu, Xi Lu, Dan Zhang, Shuo Liu, Xianjin Gu, Dan Liu, Jianwen Sun, Tiantian Zhou, Xinge Li, Yongjun Gao, Yanwei Zhao, Guoliang Cui, Shaobai Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
CoronaVac
lot-to-lot consistency
immunogenicity
safety
children and adolescents
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1320352/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1320352/full

Similar Items